• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.65% Nasdaq Down1.89%

    OncoGenex Pharmaceuticals, Inc. (OGXI)

    -NCM
    2.08 Down 0.03(1.42%) 4:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (31,849) (21,098) (14,673)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation227  100  75  
    Adjustments To Net Income(374)(4,092)(6,200)
    Changes In Accounts Receivables(7,834)(229)412  
    Changes In Liabilities5,898  (15,233)(1,434)
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(1,995)(2,941)1,557  
    Total Cash Flow From Operating Activities (35,927) (43,493) (20,263)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(253)(291)(79)
    Investments32,679  (20,897)25,147  
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities 32,426   (21,188) 25,068  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock10  54,239  219  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 10   54,239   219  
    Effect Of Exchange Rate Changes9   -  (40)
    Change In Cash and Cash Equivalents (3,482) (10,442) 4,984  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.